Day: October 14, 2021

Hyris developed a rapid T-cell test to track patients’ immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

LONDON, Oct. 14, 2021 (GLOBE NEWSWIRE) — After almost two years of fight against COVID-19, governments, NGOs, and corporations are now focusing on strategies and solutions to boost population immunity and move onto the next phase – possibly out of the pandemic.

Hyris, a global, innovation-based biotechnology company renowned for its inclusive approach to genetic analysis, offers a wide range of solutions to support medical professionals and decision-makers in the fight against COVID-19. The proprietary genetic testing Hyris System^TM has been successfully used to detect the presence of the Coronavirus on surfaces and environments (the SARS-CoV-2 Environmental test) and the infection COVID-19 into individuals (SARS-CoV-2 Human test). The tests have been able to reliably detect the presence of all the main Variants of Concern since July 2020, helping to keep people safe around the world effectively.

“Alongside with limiting the spread of SARS-CoV-2 new variants and potential hotspots, getting high immunity rates among populations is the number one priority for policymakers and health institutions,” says Stefano Lo Priore, Founder and CEO at Hyris. “Hyris integrated its solutions with a simple yet effective test, to measure a patient T-cell immune response to the SARS-CoV-2 virus, which causes COVID-19.”

The T-cell clinical test kit was developed through an exclusive licensing agreement between Hyris and Duke-NUS Medical School. “This new kit enables quick evaluation of T-cell immune responses in COVID-19 convalescent patients as well as vaccinated people,” adds Isabella Della Noce, Chief Biologist at Hyris. “This is a new dimension for vaccine strategies as we face the threat of new virus variants.”

Led by Professor Antonio Bertoletti from the Programme in Emerging Infectious Diseases at Duke-NUS, the research team discovered a simple and rapid method to measure the T-cell immune response to the SARS-CoV-2 virus. The study, titled “Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals“, was published in the Journal of Clinical Investigation.

According to Duke-NUS’ press release, this discovery allows a rapid and large-scale expansion of studies to track T-cell activity across the world while not requiring specialised or expensive equipment, helping to define the correlates of protection from T-cells and antibodies for the development of COVID-19 vaccines.

Many progressive organisations and medical centres worldwide have already chosen the Hyris System™ as the ideal ‘Point of Care’ solution in the fight against COVID-19. Such a test is a prime example of how scientific innovation is key to the fight against the SARS-CoV-2 virus. “Today, more than ever before, we need wider access to diagnostic systems and tests, but also to support and validate vaccination campaigns around the world,” concludes Lo Priore.

Contact a Hyris expert to discover how to perform beyond your current diagnostic capability info@hyris.net.

Related Files

JCI_Rapid measurement of SARS-CoV-2 spike T cells.pdf

Related Images

Image 1: Hyris supports research over COVID-19 Immunity

Hyris new Test quickly detects the body’s T-cell immune response to SARS-CoV-2

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Hyris supports research over COVID-19 Immunity

NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) — MicroEnsure (part of Micro Insurance Company), a global provider of digital insurance products, and Jazz Business, one of the largest B2B solutions provider in the nation, have entered into an industry-first strategic partnership, to provide tailored insurance products at specialized rates to Jazz’s corporate customers.

Under the partnership, customized insurance packages will be offered to Jazz’s corporate clientele and delivered through completely digital processes. Businesses can sign their employees up for these insurance plans, mitigating the financial risk of unforeseen hospitalization due to accident or sickness. With affordability being the utmost priority, the partnership is particularly beneficial to industries with a majority of blue-collar workers.

“The year 2020 was riddled with uncertainty, and it redefined the need for insurance protection products,” said Ali Naseer, Chief Business Officer at Jazz. As the only telecom offering insurance products for its corporate customers, we’re proud to partner up with MicroEnsure – a company that echoes our sentiments on the importance of digital-based processes. We look forward to a collaborative partnership that will benefit those who need it the most.”

Appreciating the partnership as a major step towards the goal of reaching out to tens of millions of uninsured and under-insured Pakistanis, Rehan Butt, MicroEnsure Pakistan CEO remarked:

“Jazz with its massive outreach is in a strong position to change the insurance fabric in Pakistan and we are excited that we have been provided with a great opportunity through this partnership to take insurance products to scores of Jazz Business customers, majority of whom are yet to experience their first-ever insurance product. MicroEnsure and its Group the Micro Insurance Company aim at providing a real digital experience to our customers characterised with a simple sign-up process and an equally simple and no quibble claim process.”

About MicroEnsure:

MicroEnsure is a part of the Micro Insurance Company Group which aims to provide insurance products and services to billions of un and under-served individuals and businesses across Asia, Africa and then Americas. The Group is the first global end-to-end digital micro-insurance provider that combines reinsurance capacity, in-country insurance licenses, world-class distribution and market-leading AI functionality to address this large market globally by providing an insurance platform that is capable of assuming various types of micro transactional insurance risks. For more details, please contact Rehan Butt at rehan.butt@microensure.com or visit www.microinsurance.com

About Jazz:

Jazz, Pakistan’s number one 4G operator and a leading digital service provider with over 67 million subscribers including 25 million 4G users. By providing the most extensive portfolio of digital value-added services, Jazz continues to be the country’s undisputed telecom leader.

About Jazz Business:

With 360-degree ICT Solutions covering Mobility, M2M, and Cloud services, Jazz Business is a ‘One Window’ Solutions provider to fully customizable B2B services. It is currently serving over 25,000 companies with smart communications and connectivity solutions to operate more efficiently and collaborate more effectively.

London, October 13, 2021

CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) today announced that it will temporarily close several of its European agricultural, commercial vehicle and powertrain manufacturing facilities in response to ongoing disruptions to the procurement environment and shortages of core components, especially semiconductors.

CNH Industrial is constantly reviewing its production schedules in response to this highly dynamic environment and plans to shut the concerned plants for no longer than eight working days in the month of October. The Company remains committed to optimizing its manufacturing operations to meet continued strong demand and best serve its dealers and customers.

CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural machinery; Case and New Holland Construction for earth moving equipment; Iveco for commercial vehicles; Iveco Bus and Heuliez Bus for buses and coaches; Iveco Astra for quarry and construction vehicles; Magirus for firefighting vehicles; Iveco Defence Vehicles for defence and civil protection; and FPT Industrial for engines and transmissions. More information can be found on the corporate website: www.cnhindustrial.com

Contacts:

Corporate Communications

Email: mediarelations@cnhind.com

Investor Relations

Email: investor.relations@cnhind.com

Attachment

• 20211013_PR_CNH Industrial_Temporary_Shutdowns_Europe